Theravance Biopharma shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Theravance Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Theravance Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Theravance Biopharma by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.1M | 213k | 14.60 |
| 2025-03-31 | $1.4M | 157k | 8.93 |
| 2024-12-31 | $2.1M | 220k | 9.41 |
| 2024-09-30 | $2.2M | 267k | 8.06 |
| 2024-06-30 | $2.2M | 259k | 8.48 |
| 2024-03-31 | $277k | 31k | 8.97 |
| 2023-12-31 | $496k | 44k | 11.24 |
| 2023-09-30 | $412k | 48k | 8.63 |
| 2023-06-30 | $526k | 51k | 10.35 |
| 2023-03-31 | $1.8M | 163k | 10.85 |
| 2022-12-31 | $2.4M | 214k | 11.22 |
| 2022-06-30 | $1.9M | 207k | 9.06 |
| 2022-03-31 | $1.7M | 173k | 9.56 |
| 2021-12-31 | $2.3M | 205k | 11.07 |
| 2021-03-31 | $587k | 29k | 20.43 |
| 2020-12-31 | $649k | 37k | 17.77 |
| 2020-09-30 | $258k | 17k | 15.05 |
| 2020-06-30 | $326k | 16k | 21.01 |
| 2020-03-31 | $366k | 16k | 23.10 |
| 2019-12-31 | $372k | 14k | 25.87 |
| 2019-09-30 | $337k | 17k | 19.45 |
| 2019-06-30 | $1.5M | 93k | 16.10 |
| 2019-03-31 | $4.5M | 200k | 22.56 |
| 2018-12-31 | $3.6M | 139k | 25.59 |
| 2018-09-30 | $391k | 12k | 32.83 |
| 2018-06-30 | $197k | 8.7k | 22.64 |
| 2018-03-31 | $239k | 9.9k | 24.16 |
| 2017-12-31 | $287k | 10k | 28.18 |
| 2017-06-30 | $1.5M | 41k | 37.04 |
| 2017-03-31 | $1.7M | 47k | 37.04 |
| 2016-12-31 | $3.4M | 91k | 37.04 |
| 2016-09-30 | $1.6M | 44k | 36.26 |
| 2016-06-30 | $2.0k | 109 | 18.35 |
| 2016-03-31 | $2.0k | 109 | 18.35 |
| 2015-12-31 | $4.0k | 260 | 15.38 |